Condition: Breast Neoplasms · Sponsor: Lund University
This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.
This description comes directly from the study's public registry record.
Åke Borg, PhD · +46-46-2752552 · ake.borg@med.lu.se
Lao Saal, MD, PhD · lao.saal@med.lu.se
Always discuss trial participation with your own doctor first.
| Hallands Hospital Halmstad | Halmstad, Sweden | Suspended |
| Helsingborg Hospital | Helsingborg, Sweden | Recruiting |
| Kirurgiska kliniken | Jönköping, Sweden | Recruiting |
| Blekinge County Hospital | Karlskrona, Sweden | Recruiting |
| Central Hospital Kristianstad | Kristianstad, Sweden | Recruiting |
| Skåne University Hospital | Lund, Sweden | Recruiting |
| Skåne University Hospital | Malmö, Sweden | Recruiting |
| Uppsala University Hospital | Uppsala, Sweden | Recruiting |
| Central Hospital Växjö | Vaxjo, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02306096